Biocon Crosses $1bn Threshold In Biosimilars Revenue

Wider Results Met With Analyst Uncertainty

 
• By Adam Zamecnik
  
Indian Economy Growth, Indian Rupee Growth
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products